Evidence map›Paper›PMID 29943129›Full record

ArticleArchives of gynecology and obstetrics2018

Conservative management of endometrial cancer: a survey amongst European clinicians.

M La Russa, I Zapardiel, M J Halaska, K Zalewski, R Laky, P Dursun, D Lindquist, V Sukhin, S Polterauer, I Biliatis

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of gynecology and obstetrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Improving response to progestin treatment of low-grade endometrial cancer.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2020
    Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 10 institutions in 8 countries.

M La RussaDepartment of Gynecological Oncology, Norfolk and Norwich University Hospital, NHS Trust, Norwich, UK.
I ZapardielGynecologic Oncology Unit, La Paz University Hospital, IdiPAZ, Madrid, Spain.
M J HalaskaDepartment of Obstetrics and Gynaecology, 3rd Medical Faculty, Charles University Prague, Faculty Hospital Kralovske Vinohrady, Srobarova 1150/50, Praha 10, 100 34, Prague, Czech Republic. mhalaska@seznam.cz.
K ZalewskiDepartment of Gynecologic Oncology, Holycross Cancer Center, Kielce, Poland.
R LakyDivision of Gynecology, Medical University Graz, Graz, Austria.
P DursunDepartment of Obstetrics and Gynecology, Baskent University School of Medicine, Ankara, Turkey.
D LindquistDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.
V SukhinDepartment of Oncogynecology, Grigoriev Institute for Medical Radiology, Kharkiv, Ukraine.
S PolterauerDepartment of Gynecology and Gynecologic Oncology, Medical University of Vienna, Vienna, Austria.
I BiliatisDepartment Gynecological Oncology, Poole NHS Trust, Poole, UK.
Başkent University · TRHospital Universitario La Paz · ESMedical University of Graz · ATMedical University of Vienna · ATMedical University of Warsaw · PLNorfolk and Norwich University Hospital · GBPoole Hospital · GBState Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine»Umeå University · SEUniversity Hospital Kralovske Vinohrady · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate differences and similarities in the clinical approach of young clinicians managing women with endometrial cancer (EC) conservatively.

methodsA web-based survey was carried out. A platform of the European Network of Young Gynaecological Oncologists (ENYGO) database was used. A 38-item multiple-choice questionnaire was used to evaluate current practice in fertility-sparing management of EC. The survey covered investigations, treatment options, follow-up and management of recurrence and future family planning. Descriptive statistics were used.

resultsOverall, 116 out of 650 (17.84%) ENYGO members responded to the survey. In 92 (79.3%) centres, the caseload of early stage EC treated conservatively was less than 10 per year. One hundred and seven responders (93.8%) believe that treatment with progestins could be offered in grade 1 EC without myometrial invasion, but a minority would recommend it even for grade 2 tumours with no myometrial invasion or grade 1 with superficial invasion. The diagnostic tool for establishing grade of tumour was hysteroscopy with dilatation and curettage in 64 (55%) centres. Medroxyprogesterone acetate represents the most commonly prescribed progestogen (55, 47.4%). In 78 (67.2%) centres, a repeat endometrial biopsy was offered after 3 months of treatment commencement. Recurrences are treated mostly with hysterectomy (81, 69.9%) with only a small number of responders recommending to repeat progestin treatment. Lynch syndrome is a contraindication for conservative management in half of the responders (57, 49.1%). Most clinicians agree that patients should be referred promptly for assisted reproductive techniques once complete response has been achieved (68, 58.6%).

conclusionsOur study shows that conservative management is increasingly offered to women affected by early stage EC wishing to preserve their fertility. Further studies and joint registries are required to evaluate safety and effectiveness of this approach in this probably growing number of patients.

Indexed as

AdultAntineoplastic Agents, HormonalConservative TreatmentDilatation and CurettageEndometrial NeoplasmsEndometriumEuropeFemaleFertility PreservationHumansHysteroscopyMedroxyprogesterone AcetateMyometriumNeoplasm Recurrence, LocalPregnancyProgestinsAntineoplastic Agents, HormonalMedroxyprogesterone AcetateProgestinsAssisted reproductionConservative managementEndometrial cancerPregnanciesProgestins

Identifiers

PMID29943129
OpenAlexW2810184501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.